<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37179568</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-889X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in molecular biosciences</Title><ISOAbbreviation>Front Mol Biosci</ISOAbbreviation></Journal><ArticleTitle>Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets.</ArticleTitle><Pagination><StartPage>1157651</StartPage><MedlinePgn>1157651</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1157651</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmolb.2023.1157651</ELocationID><Abstract><AbstractText>The emergence of persistent ill-health in the aftermath of SARS-CoV-2 infection has presented significant challenges to patients, healthcare workers and researchers. Termed long COVID, or post-acute sequelae of COVID-19 (PASC), the symptoms of this condition are highly variable and span multiple body systems. The underlying pathophysiology remains poorly understood, with no therapeutic agents proven to be effective. This narrative review describes predominant clinical features and phenotypes of long COVID alongside the data supporting potential pathogenesis of these phenotypes including ongoing immune dysregulation, viral persistence, endotheliopathy, gastrointestinal microbiome disturbance, autoimmunity, and dysautonomia. Finally, we describe current potential therapies under investigation, as well as future potential therapeutic options based on the proposed pathogenesis research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Kenny, Townsend, Savinelli and Mallon.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savinelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallon</LastName><ForeName>Patrick W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Biosci</MedlineTA><NlmUniqueID>101653173</NlmUniqueID><ISSNLinking>2296-889X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post COVID condition</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>11</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37179568</ArticleId><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="doi">10.3389/fmolb.2023.1157651</ArticleId><ArticleId IdType="pii">1157651</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28 (7), 1461&#x2013;1467. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594 (7862), 259&#x2013;264. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S., Willows S., Kulka M., Sandhu J. K. (2020). Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur. J. neurology 27 (11), 2348&#x2013;2360. 10.1111/ene.14442</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14442</ArticleId><ArticleId IdType="pmc">PMC7405269</ArticleId><ArticleId IdType="pubmed">32668062</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba G. A., Ziehr D. R., Rouvina J. N., Hariri L. P., Knipe R. S., Medoff B. D., et al. (2021). Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine 39, 101066. 10.1016/j.eclinm.2021.101066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101066</ArticleId><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R. S., Merino J., Sudre C. H., Molteni E., Berry S., et al. (2022). Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 22 (1), 43&#x2013;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in&#x223c; 4% of uninfected individuals over 70 years old and account for&#x223c; 20% of COVID-19 deaths. Sci. Immunol. 6 (62), eabl4340. 10.1126/sciimmunol.abl4340</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L. B., Zhang Q., Michailidis E., Hoffmann H-H., Zhang Y., et al. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370 (6515), eabd4585. 10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L., Venzon M., Klein J., Axelrad J. E., Zhang C., Sullivan A. P., et al. (2022). Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat. Commun. 13 (1), 5926. 10.1038/s41467-022-33395-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J. W., Wainberg M., Elkind M. S. V., Freedberg D. E. (2022). Potential long coronavirus disease 2019 gastrointestinal symptoms 6 Months after coronavirus infection are associated with mental health symptoms. Gastroenterology 162 (2), 648&#x2013;650.e2. 10.1053/j.gastro.2021.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S., Hartung F., Henkel F., Quaranta A., Kolmert J., Priller A., et al. (2022). Mild COVID-19 imprints a long-term inflammatory eicosanoid-and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 15 (3), 515&#x2013;524. 10.1038/s41385-021-00482-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan C. M., Nadella S., Zhao X., Dima R. J., Jordan-Martin N., Demestichas B. R., et al. (2022). Oral famotidine versus placebo in non-hospitalised patients with COVID-19: A randomised, double-blind, data-intense, phase 2 clinical trial. Gut 71 (5), 879&#x2013;888. 10.1136/gutjnl-2022-326952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-326952</ArticleId><ArticleId IdType="pmc">PMC8844971</ArticleId><ArticleId IdType="pubmed">35144974</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., O&#x2019;Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., et al. (2022). Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 28 (5), 879&#x2013;882. 10.1038/s41591-022-01766-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T. P., DeOre B. J., Baldwin-Leclair A., Bullock T. A., McGary H. M., Khan J. A., et al. (2020). The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood&#x2013;brain barrier. Neurobiol. Dis. 146, 105131. 10.1016/j.nbd.2020.105131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M., Greene C., Connolly R., Brennan D., Laffan A., O'Keeffe E., et al. (2022). Blood-brain barrier disruption in Long COVID-associated cognitive impairment. Berlin, Germany: Researchgate.</Citation></Reference><Reference><Citation>Canas L. S., Molteni E., Deng J., Sudre C. H., Murray B., Kerfoot E., et al. (2022). Profiling post-COVID syndrome across different variants of SARS-CoV-2. medRxiv 2022, 22278159. 10.1101/2022.07.28.22278159</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.28.22278159</ArticleId><ArticleId IdType="pmc">PMC10187990</ArticleId><ArticleId IdType="pubmed">37202336</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group (2020). Persistent symptoms in patients after acute COVID-19. Jama 324 (6), 603&#x2013;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F. J. (2018). Infectious diseases causing autonomic dysfunction. Clin. Aut. Res. 28 (1), 67&#x2013;81. 10.1007/s10286-017-0452-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-017-0452-4</ArticleId><ArticleId IdType="pubmed">28730326</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen I. H., Magnus P., Trogstad L. (2022). Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur. J. Epidemiol. 37 (5), 539&#x2013;548. 10.1007/s10654-022-00847-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L. M. W., Lee Y., Gill H., Teopiz K. M., et al. (2022). Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain, Behav. Immun. 101, 93&#x2013;135. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (2022). Post-COVID conditions: Information for healthcare providers 2022. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.
</Citation></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., et al. (2022). Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 13 (1), 446. 10.1038/s41467-021-27797-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans L. J., Khan M., Yoo S-J., Zapiec B., Van Gerven L., Van Slambrouck J., et al. (2021). Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 9 (8), e78&#x2013;e79. 10.1016/S2213-2600(21)00240-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S., Gonzalez J. C., Sievers B. L., Mallajosyula V., Chakraborty S., Dubey M., et al. (2022). Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci. Transl. Med. 14 (635), eabm7853. 10.1126/scitranslmed.abm7853</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm7853</ArticleId><ArticleId IdType="pmc">PMC8939764</ArticleId><ArticleId IdType="pubmed">35040666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S. E., Feng A., Meng W., Apostolidis S. A., Mack E., Artandi M., et al. (2021). New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 12 (1), 5417. 10.1038/s41467-021-25509-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., et al. (2022). Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut 71 (1), 222&#x2013;225. 10.1136/gutjnl-2021-324090</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Scarabelli C., Scarabelli T. M. (2004). Neurocardiogenic syncope. Bmj 329 (7461), 336&#x2013;341. 10.1136/bmj.329.7461.336</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.329.7461.336</ArticleId><ArticleId IdType="pmc">PMC506859</ArticleId><ArticleId IdType="pubmed">15297344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chularojanamontri L., Tuchinda P., Rujitharanawong C., Hunnangkul S., Pochanapan O., Panjapakkul W., et al. (2022). New-onset and exacerbated skin diseases after COVID-19 infection: A systematic review. J. Dermatol 49 (11), e419&#x2013;e421. 10.1111/1346-8138.16501</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.16501</ArticleId><ArticleId IdType="pmc">PMC9349745</ArticleId><ArticleId IdType="pubmed">35775731</ArticleId></ArticleIdList></Reference><Reference><Citation>
Clinicaltrials (2022). Paxlovid for treatment of long covid (STOP-PASC). Available at: https://clinicaltrials.gov/ct2/show/NCT05576662.
</Citation></Reference><Reference><Citation>Consiglio C. R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., et al. (2020). The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183 (4), 968&#x2013;981. 10.1016/j.cell.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G., Roldan-Valadez E., Graniel-Palafox L. E., Garcia-Cesar M., Torres-Rojas M. B., Enriquez-Garcia R., et al. (2022). Chronic thromboembolic pulmonary hypertension (cteph): A review of another sequel of severe post-covid-19 pneumonia. Curr. Probl. Cardiol. 2022, 101187. 10.1016/j.cpcardiol.2022.101187</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101187</ArticleId><ArticleId IdType="pmc">PMC8956357</ArticleId><ArticleId IdType="pubmed">35346727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A., Tseng E. K., Nieuwlaat R., Angchaisuksiri P., Blair C., Dane K., et al. (2022). American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Adv. 6 (2), 664&#x2013;671. 10.1182/bloodadvances.2021005945</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005945</ArticleId><ArticleId IdType="pmc">PMC8566097</ArticleId><ArticleId IdType="pubmed">34727173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D. M. (2022). The costs of long COVID. JAMA Health Forum 3 (5), e221809. 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V., Arroliga A. C., Bourgeois J. A., Boehm L. M., McNeal M. J., Widmer A. J., et al. (2022). Symptom clusters seen in adult COVID-19 recovery clinic care seekers. J. General Intern. Med. 38, 442&#x2013;449. 10.1007/s11606-022-07908-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07908-4</ArticleId><ArticleId IdType="pmc">PMC9663188</ArticleId><ArticleId IdType="pubmed">36376627</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re'em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604 (7907), 697&#x2013;707. 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola O. M., Brand&#xe3;o C. O., Gomes Y. C. P., Siqueira M., Soares C. N., Lima M. A. S. D., et al. (2021). Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int. J. Infect. Dis. 102, 155&#x2013;162. 10.1016/j.ijid.2020.10.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.044</ArticleId><ArticleId IdType="pmc">PMC7591319</ArticleId><ArticleId IdType="pubmed">33127503</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Strasser Z. H., Brat G. A., Semenov Y. R., Aaron J. R., Agapito G., et al. (2021). Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 19 (1), 249. 10.1186/s12916-021-02115-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02115-0</ArticleId><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Bateman, A. C. Bested, H. F. Bonilla, B. V. Chheda, L. Chu, J. M. Curtin, et al. (2021). Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo clinic proceedings (Amsterdam, Netherlands: Elsevier; ).</Citation><ArticleIdList><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Kenny, K. McCann, C. O&#x2019;Brien, S. Savinelli, W. Tinago, O. Yousif, et al. (2022). Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open forum infectious diseases (Oxford, United Kingdom: Oxford University Press US; ).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A. C., Song E., Lee M-H., Wood J., et al. (2022). Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185 (14), 2452&#x2013;2468.e16. 10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J. D., Florencio L. L., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Torres-Macho J., et al. (2022). Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection 51, 61&#x2013;69. 10.1007/s15010-022-01822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Fesharaki-Zadeh A., Lowe N., Arnsten A. F. (2023). Clinical experience with the &#x3b1;2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in &#x201c;Long-COVID19&#x201d;. Neuroimmunol. Rep. 3, 100154. 10.1016/j.nerep.2022.100154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nerep.2022.100154</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J. K., Boppana S., Perez M. D., Sarkar S., Lowman K. E., Qin K., et al. (2021). Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J. Clin. investigation 131 (1), e140491. 10.1172/JCI140491</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Ni Cheallaigh C., Bergin C., Martin&#x2010;Loeches I., Browne P., et al. (2020). More on COVID-19 coagulopathy in Caucasian patients. Br. J. Haematol. 189, 1060&#x2013;1061. 10.1111/bjh.16791</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16791</ArticleId><ArticleId IdType="pmc">PMC7272907</ArticleId><ArticleId IdType="pubmed">32400024</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S. E., Townsend L., Karampini E., Elliott S., Conlon N., et al. (2022). Sustained VWF&#x2010;ADAMTS&#x2010;13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thrombosis Haemostasis 20, 2429&#x2013;2438. 10.1111/jth.15830</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Forshaw D., Wall E. C., Prescott G., Dehbi H-M., Green A., Attree E., et al. (2022). STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, phase III, open label, adaptive platform randomised drug trial in individuals with long COVID: A structured protocol. medRxiv 2022, 22277893. 10.1101/2022.07.21.22277893</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.21.22277893</ArticleId><ArticleId IdType="pmc">PMC9931100</ArticleId><ArticleId IdType="pubmed">36791116</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J. A., Thorpe L. E., Simon N. M., de Havenon A., Yaghi S., Sabadia S. B., et al. (2022). Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study. Plos one 17 (9), e0275274. 10.1371/journal.pone.0275274</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J. C., Muecksch F., Finkin S., Tokuyama M., et al. (2021). Evolution of antibody immunity to SARS-CoV-2. Nature 591 (7851), 639&#x2013;644. 10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Chu W., Duan J., Li J., Ma W., Hu C., et al. (2021). Six-month outcomes of post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia. Front. Mol. Biosci. 8, 640763. 10.3389/fmolb.2021.640763</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.640763</ArticleId><ArticleId IdType="pmc">PMC8217604</ArticleId><ArticleId IdType="pubmed">34169092</ArticleId></ArticleIdList></Reference><Reference><Citation>George P. M., Reed A., Desai S. R., Devaraj A., Faiez T. S., Laverty S., et al. (2022). A persistent neutrophil-associated immune signature characterizes post&#x2013;COVID-19 pulmonary sequelae. Sci. Transl. Med. 14 (671), eabo5795. 10.1126/scitranslmed.abo5795</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5795</ArticleId><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L. B., Dweep H., Yin X., Wang H., Damra M., Goldman A. R., et al. (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12, 686240. 10.3389/fimmu.2021.686240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L. B., Peluso M. J., Ding J., Kenny G., Zilberstein N. F., Koshy J., et al. (2022). Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling. JCI Insight 7 (15), e164813. 10.1172/jci.insight.164813</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.164813</ArticleId><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J. E., Okyay R. A., Licht W. E., Hurley D. J. (2021). Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 10 (6), 763. 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P. K., Mohammed T. O., Mahmoud A., Zaidi A. J., Nguyen C. V. (2022). COVID-19 infection leading to acute pustular dermatoses. Arch. Dermatol Res. 2022, 1&#x2013;13. 10.1007/s00403-022-02450-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00403-022-02450-z</ArticleId><ArticleId IdType="pmc">PMC9628627</ArticleId><ArticleId IdType="pubmed">36319703</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D. E. (2022). Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 20 (6), e3001687. 10.1371/journal.pbio.3001687</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S. A., Ebner L., Aubry-Beigelman C., Bridevaux P. O., Brutsche M., Clarenbach C., et al. (2021). Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 57 (4), 2003690. 10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall V. J., Foulkes S., Charlett A., Atti A., Monk E. J., Simmons R., et al. (2021). SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in england: A large, multicentre, prospective cohort study (SIREN). Lancet 397 (10283), 1459&#x2013;1469. 10.1016/S0140-6736(21)00675-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00675-9</ArticleId><ArticleId IdType="pmc">PMC8040523</ArticleId><ArticleId IdType="pubmed">33844963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M., Lely A., Gv N., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathology 203 (2), 631&#x2013;637. 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge M. S., Tansey C. M., Matt&#xe9; A., Tomlinson G., Diaz-Granados N., Cooper A., et al. (2011). Functional disability 5 Years after acute respiratory distress syndrome. N. Engl. J. Med. 364 (14), 1293&#x2013;1304. 10.1056/NEJMoa1011802</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1011802</ArticleId><ArticleId IdType="pubmed">21470008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S. D., et al. (2006). Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. Bmj 333 (7568), 575. 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoepel W., Chen H-J., Geyer C. E., Allahverdiyeva S., Manz X. D., de Taeye S. W., et al. (2021). High titers and low fucosylation of early human anti&#x2013;SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci. Transl. Med. 13 (596), eabf8654. 10.1126/scitranslmed.abf8654</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8654</ArticleId><ArticleId IdType="pmc">PMC8158960</ArticleId><ArticleId IdType="pubmed">33979301</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A. T., Garcia-Carreras B., Hitchings M. D., Yang B., Katzelnick L. C., Rattigan S. M., et al. (2020). A systematic review of antibody mediated immunity to coronaviruses: Kinetics, correlates of protection, and association with severity. Nat. Commun. 11 (1), 4704&#x2013;4716. 10.1038/s41467-020-18450-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18450-4</ArticleId><ArticleId IdType="pmc">PMC7499300</ArticleId><ArticleId IdType="pubmed">32943637</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 397 (10270), 220&#x2013;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (10223), 497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., et al. (2021). 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 398 (10302), 747&#x2013;758. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes E. C., Saleh D. (2022). Telogen effluvium. StatPearls. Treasure island (FL). Florida, United States: StatPearls Publishing LLC. StatPearls Publishing Copyright &#xa9; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">28613598</ArticleId></ArticleIdList></Reference><Reference><Citation>Isa A., Kasprowicz V., Norbeck O., Loughry A., Jeffery K., Broliden K., et al. (2005). Prolonged activation of virus-specific CD8+ T cells after acute B19 infection. PLoS Med. 2 (12), e343. 10.1371/journal.pmed.0020343</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020343</ArticleId><ArticleId IdType="pmc">PMC1274280</ArticleId><ArticleId IdType="pubmed">16253012</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S. M., Landers D. B., Hollenberg S. M., Turi Z. G., Glotzer T. V., Tancredi J., et al. (2022). Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J. Am. Coll. Cardiol. 79 (23), 2325&#x2013;2330. 10.1016/j.jacc.2022.03.357</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y., Luo L., Chen Y., Westerberg L. S., Zhou P., Xu Z., et al. (2021). SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct. Target. Ther. 6 (1), 345&#x2013;413. 10.1038/s41392-021-00749-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00749-3</ArticleId><ArticleId IdType="pmc">PMC8456405</ArticleId><ArticleId IdType="pubmed">34552055</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J., Buck P., Zipfel S., Stengel A. (2022). Post-COVID-19 fatigue: A systematic review. Front. Psychiatry 13, 947973. 10.3389/fpsyt.2022.947973</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R. K. F., Faria-Urbina M., Felsenstein D., Oaklander A. L., et al. (2021). Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest 160 (2), 642&#x2013;651. 10.1016/j.chest.2021.01.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O'Brien C., Savinelli S., O'Broin C., Tinago W., et al. (2022). Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect. Dis. 9 (2), ofac060. 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury D. S., Cromer D., Reynaldi A., Schlub T. E., Wheatley A. K., Juno J. A., et al. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27 (7), 1205&#x2013;1211. 10.1038/s41591-021-01377-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01377-8</ArticleId><ArticleId IdType="pubmed">34002089</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kingdom OonsU (2022). Self-reported long COVID and labour market outcomes, UK. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidandlabourmarketoutcomesuk2022/selfreportedlongcovidandlabourmarketoutcomesuk2022.
</Citation></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R. M., Gehlhausen J. R., et al. (2022). Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022, 22278592. 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R. M., Gehlhausen J. R., et al. (2022). Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022, 22278592. 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong K. C. N. K., Mehta P. R., Shukla G., Mehta A. R. (2020). COVID-19, SARS and MERS: A neurological perspective. J. Clin. Neurosci. 77, 13&#x2013;16. 10.1016/j.jocn.2020.04.124</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.04.124</ArticleId><ArticleId IdType="pmc">PMC7198407</ArticleId><ArticleId IdType="pubmed">32417124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P., O&#x2019;Sullivan O., Houston A., Barker-Davies R., May S., Mills D., et al. (2022). Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart rhythm. 19 (4), 613&#x2013;620. 10.1016/j.hrthm.2021.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M. H-B., Wing Y-K., Yu M. W-M., Leung C-M., Ma R. C., Kong A. P., et al. (2009). Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Archives Intern. Med. 169 (22), 2142&#x2013;2147. 10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Langen U. H., Ayloo S., Gu C. (2019). Development and cell biology of the blood-brain barrier. Annu. Rev. Cell Dev. Biol. 35, 591&#x2013;613. 10.1146/annurev-cellbio-100617-062608</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062608</ArticleId><ArticleId IdType="pmc">PMC8934576</ArticleId><ArticleId IdType="pubmed">31299172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H., Perl D. P., Nair G., Li W., Maric D., Murray H., et al. (2021). Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 384 (5), 481&#x2013;483. 10.1056/NEJMc2033369</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. H., Shin H-S., Park H. Y., Kim J. L., Lee J. J., Lee H., et al. (2019). Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry investig. 16 (1), 59&#x2013;64. 10.30773/pi.2018.10.22.3</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X., Li D., Ma Z., Zhang L., Zheng B., Li Z., et al. (2022). 12-Month post-discharge liver function test abnormalities among patients with COVID-19: A single-center prospective cohort study. Front. Cell. Infect. Microbiol. 12, 864933. 10.3389/fcimb.2022.864933</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.864933</ArticleId><ArticleId IdType="pmc">PMC9046934</ArticleId><ArticleId IdType="pubmed">35493732</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K. M., Watson R. O., Schneider J. M., Neff C. P., Yamada E., Zhang M., et al. (2022). SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLOS Pathog. 18 (5), e1010359. 10.1371/journal.ppat.1010359</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J. W. Y., Su Q., Yeoh Y. K., Lui G. C-Y., Ng S. S. S., et al. (2022). Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71 (3), 544&#x2013;552. 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C., Abdelsalam A., D&#x2019;Addio F., Nasr M. B., Assi E., Usuelli V., et al. (2021). PD-1 blockade counteracts post&#x2013;COVID-19 immune abnormalities and stimulates the anti&#x2013;SARS-CoV-2 immune response. JCI insight 6 (24), e146701. 10.1172/jci.insight.146701</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund L. C., Hallas J., Nielsen H., Koch A., Mogensen S. H., Brun N. C., et al. (2021). Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: A Danish population-based cohort study. Lancet Infect. Dis. 21 (10), 1373&#x2013;1382. 10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., et al. (2022). Prognostic factors for post-COVID-19 syndrome: A systematic review and meta-analysis. J. Clin. Med. 11 (6), 1541. 10.3390/jcm11061541</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurol. 77 (6), 683&#x2013;690. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon D. E., Gallman A. E., Hruza G. J., Rosenbach M., Lipoff J. B., Desai S. R., et al. (2021). Long COVID in the skin: A registry analysis of COVID-19 dermatological duration. Lancet Infect. Dis. 21 (3), 313&#x2013;314. 10.1016/S1473-3099(20)30986-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderbacher C. R., Ramirez S. I., Dan J. M., Grifoni A., Hastie K. M., Weiskopf D., et al. (2020). Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183 (4), 996&#x2013;1012. 10.1016/j.cell.2020.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. (2011). Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 11 (1), 37. 10.1186/1471-2377-11-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E. F., Vance S. E., Dahlen A., Hedlin H., et al. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 3, 371&#x2013;387.e9. 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton J., Okonkwo O., Sutcliffe K., Seth A., Shin J., Jones D. (2007). Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM Int. J. Med. 100 (8), 519&#x2013;526. 10.1093/qjmed/hcm057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcm057</ArticleId><ArticleId IdType="pubmed">17617647</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K. I., Catahay J. A., Velasco J. V., Pastrana A., Ver A. T., Pangilinan F. C., et al. (2022). Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine 53, 101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K., Townsend L., Dowds J., Bannan C., Nadarajan P., Kent B., et al. (2022). 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: A longitudinal cohort study. Respir. Res. 23 (1), 115&#x2013;211. 10.1186/s12931-022-02032-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02032-7</ArticleId><ArticleId IdType="pmc">PMC9067558</ArticleId><ArticleId IdType="pubmed">35509060</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B. K., Francisco E. B., Yogendra R., Long E., Pise A., Rodrigues H., et al. (2022). Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 12, 5526. 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Deveau T-M., Munter S. E., Ryder D. M., Buck A. M., Beck-Engeser G., et al. (2022). Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. J. Clin. Investigation 2022, 22276660. 10.1101/2022.06.21.22276660</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276660</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Lu S., Tang A. F., Durstenfeld M. S., Ho H., Goldberg S. A., et al. (2021). Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 224 (11), 1839&#x2013;1848. 10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Mitchell A., Wang C. Y., Takahashi S., Hoh R., Tai V., et al. (2022). Low prevalence of interferon &#x3b1; autoantibodies in people experiencing symptoms of post&#x2013;coronavirus disease 2019 (COVID-19) conditions, or long COVID. J. Infect. Dis. 227, 246&#x2013;250. 10.1093/infdis/jiac372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-G&#xf3;mez A., Vitall&#xe9; J., Gasca-Capote C., Gutierrez-Valencia A., Trujillo-Rodriguez M., Serna-Gallego A., et al. (2021). Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell. Mol. Immunol. 18 (9), 2128&#x2013;2139. 10.1038/s41423-021-00728-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00728-2</ArticleId><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="pubmed">34290398</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C., Patel S. K., et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23 (2), 210&#x2013;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V. O., Carerj M. L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265&#x2013;1273. 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin J. M., Quer G., Ramos E., Baca-Motes K., Gadaleta M., Topol E. J., et al. (2021). Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw. Open 4 (7), e2115959&#x2013;e. 10.1001/jamanetworkopen.2021.15959</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.15959</ArticleId><ArticleId IdType="pmc">PMC8264646</ArticleId><ArticleId IdType="pubmed">34232306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E., Agati L. B., Calderaro D., Aguiar V. C. R., Spyropoulos A. C., de Oliveira C. C. C., et al. (2022). Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): An open-label, multicentre, randomised, controlled trial. Lancet 399 (10319), 50&#x2013;59. 10.1016/S0140-6736(21)02392-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J. T., Blau H., Casiraghi E., Bergquist T., Loomba J. J., Callahan T. J., et al. (2023). Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes. EBioMedicine 87, 104413. 10.1016/j.ebiom.2022.104413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy-Jardin M., Duthoit L., Perez T., Felloni P., Faivre J-B., Fry S., et al. (2021). Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients. EClinicalMedicine 34, 100778. 10.1016/j.eclinm.2021.100778</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100778</ArticleId><ArticleId IdType="pmc">PMC8008988</ArticleId><ArticleId IdType="pubmed">33817609</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud M., Thibault C., Le Normand F., Mcdonald E. G., Gallix B., Debry C., et al. (2021). Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw. open 4 (6), e2115352. 10.1001/jamanetworkopen.2021.15352</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.15352</ArticleId><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach A., Chikwe J., Catarino P., Rampolla R., Noble P. W., Megna D., et al. (2022). Lung transplantation for covid-19&#x2013;related respiratory failure in the United States. N. Engl. J. Med. 386 (12), 1187&#x2013;1188. 10.1056/NEJMc2117024</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2117024</ArticleId><ArticleId IdType="pmc">PMC8809503</ArticleId><ArticleId IdType="pubmed">35081299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S., Tymoszuk P., Ausserhofer D., Rass V., Pizzini A., Nordmeyer G., et al. (2022). Phenotyping of acute and persistent coronavirus disease 2019 features in the outpatient setting: Exploratory analysis of an international cross-sectional online survey. Clin. Infect. Dis. 75 (1), e418&#x2013;e431. 10.1093/cid/ciab978</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y., Giovini M., Leone M., Pizzilli G., Kortgen A., Bauer M., et al. (2020). Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review. Ann. intensive care 10 (1), 124&#x2013;213. 10.1186/s13613-020-00741-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00741-0</ArticleId><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti G., Gerlach T., Jansen J. M., Molle A., Elbahesh H., Ludlow M., et al. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Sci. Rep. 10 (1), 21447&#x2013;21510. 10.1038/s41598-020-78506-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78506-9</ArticleId><ArticleId IdType="pmc">PMC7722724</ArticleId><ArticleId IdType="pubmed">33293664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho-Shimizu V., Brodin P., Cobat A., Biggs C. M., Toubiana J., Lucas C. L., et al. (2021). SARS-CoV-2&#x2013;related mis-C: A key to the viral and genetic causes of kawasaki disease? J. Exp. Med. 218 (6), e20210446. 10.1084/jem.20210446</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210446</ArticleId><ArticleId IdType="pmc">PMC8080850</ArticleId><ArticleId IdType="pubmed">33904890</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P. M., Cullinan M., Lutchmansingh D. D., Gulati M., et al. (2022). Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest 161 (1), 54&#x2013;63. 10.1016/j.chest.2021.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Oliveira R. K. F., Naeije R., Oldham W. M., Faria-Urbina M., Waxman A. B., et al. (2021). Systemic vascular distensibility relates to exercise capacity in connective tissue disease. Rheumatol. Oxf. 60 (3), 1429&#x2013;1434. 10.1093/rheumatology/keaa510</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa510</ArticleId><ArticleId IdType="pubmed">33001175</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith N., Poss&#xe9;m&#xe9; C., Bondet V., Sugrue J., Townsend L., Charbit B., et al. (2022). Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. Nat. Commun. 13 (1), 7254&#x2013;7314. 10.1038/s41467-022-34895-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34895-1</ArticleId><ArticleId IdType="pmc">PMC9700809</ArticleId><ArticleId IdType="pubmed">36434007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller M. C., Liang C. J., Marques A. R., Chung J. Y., Shanbhag S. M., Fontana J. R., et al. (2022). A longitudinal study of COVID-19 sequelae and immunity: Baseline findings. Ann. Intern. Med. 175, 969&#x2013;979. 10.7326/M21-4905</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M. N., Eggelbusch M., Naddaf E., Gerrits K. H. L., van der Schaaf M., van den Borst B., et al. (2022). Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J. Cachexia Sarcopenia Muscle 13 (1), 11&#x2013;22. 10.1002/jcsm.12896</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Filgueiras I. S., Kedor C., Freitag H., Wittke K., Bauer S., et al. (2022). Dysregulated autoantibodies targeting vaso-and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front. Immunol. 13, 981532. 10.3389/fimmu.2022.981532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffels A. A. F., van Voorthuizen E. L., van Hees H. W. H., Peters J. B., van Helvoort H. A. C., Voermans N. C., et al. (2022). Longitudinal analysis of quadriceps muscle strength in patients with previous COVID-19 hospitalization and in patients with post-acute sequelae following mild COVID-19. Nutrients 14 (20), 4319. 10.3390/nu14204319</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204319</ArticleId><ArticleId IdType="pmc">PMC9608500</ArticleId><ArticleId IdType="pubmed">36297002</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D. G., Ng R. H., Wang K., Choi J., et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185 (5), 881&#x2013;895. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K. M., et al. (2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28 (8), 1706&#x2013;1714. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. (2021). Attributes and predictors of long COVID. Nat. Med. 27 (4), 626&#x2013;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X. G., Li J. Z., Alter G., et al. (2022). Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 76, e487&#x2013;e490. 10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P., Adamo S., Deng Y., Cervia C., Zurbuchen Y., Chevrier S., et al. (2022). T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19. Allergy 77 (8), 2468&#x2013;2481. 10.1111/all.15372</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15372</ArticleId><ArticleId IdType="pmc">PMC9347640</ArticleId><ArticleId IdType="pubmed">35567391</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B. K. J., Han R., Zhao J. J., Tan N. K. W., Quah E. S. H., Tan C. J-W., et al. (2022). Prognosis and persistence of smell and taste dysfunction in patients with Covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ 378, e069503. 10.1136/bmj-2021-069503</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J. R., Husain M., Luciano S., Harrison P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry 8, 416&#x2013;427. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., et al. (2022). Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 22 (1), 211. 10.1186/s12879-022-07153-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L., Fadle N., Regitz E., Preuss K. D., Neumann F., Cetin O., et al. (2022). Autoantibodies against SUMO1-DHX35 in long-COVID. J. Transl. Autoimmun. 5, 100171. 10.1016/j.jtauto.2022.100171</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100171</ArticleId><ArticleId IdType="pmc">PMC9675633</ArticleId><ArticleId IdType="pubmed">36425003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T., Wu J., Chen T., Li J., Yan S., Zhou Y., et al. (2022). Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI insight 7 (4), e155827. 10.1172/jci.insight.155827</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A. H., Jones K., Dunne J., Mooney A., Gaffney F., et al. (2020). Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. Plos one 15 (11), e0240784. 10.1371/journal.pone.0240784</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A. H., Naughton A., Imangaliyev S., Dunne J., Kiersey R., et al. (2022). Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression. Heliyon 8 (4), e09230. 10.1016/j.heliyon.2022.e09230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e09230</ArticleId><ArticleId IdType="pmc">PMC8973020</ArticleId><ArticleId IdType="pubmed">35386227</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A. H., Naughton A., Kiersey R., Holden D., Gardiner M., et al. (2021). Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health. Front. Immunol. 12, 676932. 10.3389/fimmu.2021.676932</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676932</ArticleId><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin&#x2010;Loeches I., Bannan C., Nadarajan P., et al. (2021). Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J. Thrombosis Haemostasis 19 (4), 1064&#x2013;1070. 10.1111/jth.15267</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Moloney D., Finucane C., McCarthy K., Bergin C., Bannan C., et al. (2021). Fatigue following COVID-19 infection is not associated with autonomic dysfunction. PloS one 16 (2), e0247280. 10.1371/journal.pone.0247280</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247280</ArticleId><ArticleId IdType="pmc">PMC7906457</ArticleId><ArticleId IdType="pubmed">33630906</ArticleId></ArticleIdList></Reference><Reference><Citation>
USA DoHaHS (2022). National research action plan on long COVID. Available at: https://www.covid.gov/assets/files/National-Research-Action-Plan-on-Long-COVID-08012022.pdf.
</Citation></Reference><Reference><Citation>Varga Z., Flammer A. J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A. S., et al. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet 395 (10234), 1417&#x2013;1418. 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas Centanaro G., Calle Rubio M., &#xc1;lvarez-Sala Walther J. L., Martinez-Sagasti F., Albuja Hidalgo A., Herranz Hern&#xe1;ndez R., et al. (2022). Long-term outcomes and recovery of patients who survived COVID-19: LUNG INJURY COVID-19 study. Open Forum Infect. Dis. 9 (4), ofac098. 10.1093/ofid/ofac098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac098</ArticleId><ArticleId IdType="pmc">PMC8903519</ArticleId><ArticleId IdType="pubmed">35360197</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. (2021). NICE guideline on long COVID. Lancet Respir. Med. 9 (2), 129. 10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt F. A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Magnusson M., Mackman N., et al. (2021). Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 5 (3), 756&#x2013;759. 10.1182/bloodadvances.2020003968</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A., Amanat F., Firpo A., Altman D. R., Bailey M. J., Mansour M., et al. (2020). Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 370 (6521), 1227&#x2013;1230. 10.1126/science.abd7728</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7728</ArticleId><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E. Y., Mao T., Klein J., Dai Y., Huck J. D., Jaycox J. R., et al. (2021). Diverse functional autoantibodies in patients with COVID-19. Nature 595 (7866), 283&#x2013;288. 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Li Y., Yue Y., Yuan C., Kang J. H., Chavarro J. E., et al. (2023). Adherence to healthy lifestyle prior to infection and risk of post&#x2013;COVID-19 condition. JAMA Intern. Med. 183 (3), 232&#x2013;241. 10.1001/jamainternmed.2022.6555</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.6555</ArticleId><ArticleId IdType="pmc">PMC9989904</ArticleId><ArticleId IdType="pubmed">36745445</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J., Li Y., Li J., Shen L., Zhu L., Liang Y., et al. (2021). Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol. Hepatol. 6 (5), 344&#x2013;346. 10.1016/S2468-1253(21)00076-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(21)00076-5</ArticleId><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., et al. (2022). Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13 (1), 1957&#x2013;2010. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2021). A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Geneva: World Health Organization.</Citation></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., De Biasi S., Hampel M., et al. (2022). Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front. Immunol. 13, 886431. 10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T. J., Yu A. C., Lee J. T. (2022). Management of post-COVID-19 olfactory dysfunction. Curr. Treat. Options Allergy 9, 1&#x2013;18. 10.1007/s40521-021-00297-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-021-00297-9</ArticleId><ArticleId IdType="pmc">PMC8723803</ArticleId><ArticleId IdType="pubmed">35004126</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. (2022). Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes and Endocrinol. 10 (5), 311&#x2013;321. 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28 (3), 583&#x2013;590. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X-W., Wu X-X., Jiang X-G., Xu K-J., Ying L-J., Ma C-L., et al. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of wuhan, China: Retrospective case series. bmj 2020, m606. 10.1136/bmj.m606</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m606</ArticleId><ArticleId IdType="pmc">PMC7224340</ArticleId><ArticleId IdType="pubmed">32075786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K., Zuo T., Lui G. C-Y., Zhang F., Liu Q., Li A. Y., et al. (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70 (4), 698&#x2013;706. 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S., Klopfenstein T., Mercier J., Kadiane-Oussou N. J., Lan Cheong Wah L., Royer P. Y., et al. (2021). Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients. Infection 49 (2), 361&#x2013;365. 10.1007/s15010-020-01442-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01442-3</ArticleId><ArticleId IdType="pmc">PMC7221233</ArticleId><ArticleId IdType="pubmed">32410112</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zang C., Xu Z., Zhang Y., Xu J., Bian J., et al. (2022). Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 29, 226&#x2013;235. 10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Mei Q., Zhang Z., Walline J. H., Liu Y., Zhu H., et al. (2022). Risk for newly diagnosed diabetes after COVID-19: A systematic review and meta-analysis. BMC Med. 20 (1), 444. 10.1186/s12916-022-02656-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Chen J., Tan S., Dong T., Jiang H., Zheng J., et al. (2018). Prolonged evolution of virus-specific memory T cell immunity after severe avian influenza A (H7N9) virus infection. J. virology 92 (17), 010244&#x2013;e1118. 10.1128/JVI.01024-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01024-18</ArticleId><ArticleId IdType="pmc">PMC6096810</ArticleId><ArticleId IdType="pubmed">29925664</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M. E., Hastie C., Roderick P., Yao G., et al. (2022). Characteristics and impact of long covid: Findings from an online survey. PloS one 17 (3), e0264331. 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>